MedPath

Evaluating the ease of secretion clearance with flutter device compared to lung FLute in patients with Bronchiectasis

Recruiting
Conditions
Bronchiectasis
Respiratory - Other respiratory disorders / diseases
Physical Medicine / Rehabilitation - Physiotherapy
Registration Number
ACTRN12614001072606
Lead Sponsor
Yasmin Silva
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Diagnosis of non cystic fibrosis Bronchiectasis (diagnosed on high resolution computerised tomography) who should produce greater than 25ml of sputum per day.

Exclusion Criteria

Current pneumothorax, untreated cor pulmonale, Haemoptysis, patients with an exacerbation from baseline (defined as a sustained increase in sputum purulence or volume over three or more day in the 4 weeks prior or during the study that required medical intervention and prescription of antibioitics) or if they were hospitalised during the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The total amount of sputum collected is the amout of sputum collected when using the devices lasting 5-10 minutes untill the end point plus from that end point during and up to 30 mintues after was defined as total wet sputum. <br> <br><br>This sputum would be weighed using a A and D HL-i Digital Compact Scale (accurate to 200 x 0.1g) will be used for all weights. A pre-weighed cup will be given to each patient and the cup and sputum contents will be re weighed to calcuate the wet weight of sputum. <br>[The total amount of sputum collected (during treatement until end point and then up to 30 minutes after from end point) ];From the total wet sputum will then be dired in a mocrowave oven (300Watts for 10 minutes) and re-weighed to calculate the dry weight of sputum. <br><br>[The total amount of sputum collected (during treatement until end point and then up to 30 minutes after end point) ]
Secondary Outcome Measures
NameTimeMethod
ikert scale to assess acceptability and tolerability of the devices. This is one scale with 8 questions. Thus only one secondary outcome measure. <br>The 8 questions had a rating scale of 1-7 (strogly disagree to strongly agree). <br>The 8 questions were<br>1. Assisted you with clearing secretions<br>2. It was easy to understand instructions<br>3. It was simple to use<br>4. The device made me tired<br>5. The device caused discomfort to use<br>6. Using the device is time consuming<br>7. Using the device would interfere with your everyday life<br>8. Using the device would cause embarrassment[At the end of each treament they will fill up a Likert Scale for each treament. ]
© Copyright 2025. All Rights Reserved by MedPath